跳至主要内容
临床试验/NCT01765374
NCT01765374已完成4 期

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

University Hospital, Rouen7 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
7
主要终点
global score of power-doppler activity measured by ultrasonography on 12 joints

研究概览

简要总结

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • failure to at least one TNF-blocking agent

排除标准

  • pregnant or childbearing woman
  • Rituximab contraindication
  • woman unable to use contraceptive means

研究组 & 干预措施

rituximab

Experimental

Only one arm; all patients are treated by rituximab (monotherapy or in combination with conventional DMARD)

干预措施: ESAOTE MyLab60 (Device)

rituximab

Experimental

Only one arm; all patients are treated by rituximab (monotherapy or in combination with conventional DMARD)

干预措施: Rituximab (Drug)

结局指标

主要结局

global score of power-doppler activity measured by ultrasonography on 12 joints

时间窗: at 6 months after initiation of rituximab and then every 2 month over the follow-up period (18 months)

Each time point will be assessed since the main objective of the study is to detect the time of sonographic relapse prior to clinical relapse

次要结局

未报告次要终点

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验